RxDoctor Payments Data

Bozena Sabala, DO

Family Medicine · Clearwater, FLNPI 1790706406

Payments from drug & device makers

$3,569in general payments, 2019–2025

Across 130 payments — averaging $27.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$1K
  • AstraZeneca$711
  • Novo Nordisk$512
  • AbbVie$311
  • Esperion Therapeutics, Inc.$302
  • Merck$232
  • plus $480 from 9 others

What the payments were for

  • Food & beverage$3,562100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,569 in reported general payments places this provider in the 80th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$33,310
Medicare patients
78
Services billed
329

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide31$38,196
TrulicityDulaglutide15$22,878
JardianceEmpagliflozin14$15,452
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$11,568
Ibandronate Sodium33$1,164
Rosuvastatin Calcium90$1,091
Np ThyroidThyroid,pork13$930
Buspirone Hcl64$619
Atorvastatin Calcium61$605
Gabapentin18$583
Fluticasone Propionate31$558
Lisinopril45$463
Pravastatin Sodium32$380
Enalapril Maleate45$356
Amlodipine Besylate64$355

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$512$38,19631 claims
Lilly USA, LLCTrulicity$1,021$22,87815 claims
AstraZenecaBreztri Aerosphere$711$11,56818 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Clearwater

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →